The 14th Congress of the European Pain Federation EFIC, taking place in Lyon, France, from 24–26 April 2025, is the premier multidisciplinary meeting for healthcare professionals and researchers dedicated to pain science. At #EFIC2025, pharmacologists will gain cutting-edge insights into the latest advancements in pain pharmacotherapy, including novel drug targets, evolving treatment strategies, and emerging research on analgesic mechanisms. Sessions will explore topics such as monoclonal antibody therapies for chronic pain, psychedelics in pain management, opioid use in perioperative care, and innovative approaches to neuropathic pain treatment. Join leading experts as they present groundbreaking findings on receptor channel mechanisms, topiceuticals for chronic pain, and the latest developments in pharmacological interventions for conditions such as rheumatoid arthritis, diabetic polyneuropathy, and fibromyalgia.
These sessions focus on pharmacologists at #EFIC2025:
| Type | Name | Speaker |
|---|---|---|
| Plenary Sessions | How side-effects may improve analgesic treatment efficacy |
Chair: Susanne Becker, Germany Christian Büchel, Germany |
| Joint Plenary Lecture with the European Headache Federation (EHF): Monoclonal antibody therapies for chronic pain |
Chair: Luis Garcia-Larrea, France Simona Sacco, Italy Martin Schmelz, Germany |
|
| Psychedelics in chronic pain and mental health disorders |
Chair: Caterina Maria Leone, Italy Kim Kuypers, Netherlands |
|
| Refresher Course | ||
| Clinical Masterclass: Preoperative and post-operative opioids |
Chad Brummett, United States Eske Aasvang, Denmark Siri Leknes, Norway |
|
| Clinical Masterclass : Topiceuticals for Chronic Pain |
Gisele Pickering, France Paul Farquhar Smith, United Kingdom David Magee, United Kingdom Bart Morlion, Belgium |
|
| Topical Workshops | ||
|
Painful Diabetic Polyneuropathy From Bench To Bedside: Novel Pathophysiological Mechanisms, Diagnostic Test-Oriented Stratification, and Mechanisms-Based Therapeutic Challenges
|
Oral Abstract Presenter: Trine Andresen, Denmark Eleonora Galosi, Italy Daniela Maria Menichella, United States Xavier Moisset, France |
|
| Revised Treatment Guidelines For Neuropathic Pain: Pharmacotherapy And Neuromodulation |
Chair: Xavier Moisset, France Nadia Soliman , United Kingdom Nadine Attal, France Poster Presenter: Denys Fontaine, France |
|
| Too Much Or Too Little? An Overview Of Opioid Epidemics In The World |
Anne-Priscille Trouvin, France Patrice Forget, United Kingdom Yacine Hadjiat, France Oral Abstract Presenter: Elsemiek Jansen – Groot Koerkamp, Netherlands) |
|
| Chronic Pain And Substance Use Disorders: Co-Morbidities And Treatment Solutions |
Chair: Martin Cheatle, United States Mark Ilgen, United States Marian Clarke, Ireland Martin Cheatle, United States Patrice Forget, United Kingdom |
|
| Receptor Channels: From Molecular Mechanisms to Therapeutic Targets for Treating Acute and Chronic Pain |
Romina Nassini, Italy Vanessa Olzon Zambelli, Brazil Eric R. Gross, United States Oral Abstract Presenter: Nadine Gheziel, France |
|
| Intrathecal drug delivery to treat refractory pain |
Denis Dupoiron, France Maria Luz Padilla del Rey, Switzerland Denis Dupoiron, France Sam Eldabe, United Kingdom |
|
| Innovative Approaches to Pain Management in Rheumatoid Arthritis, Mapping Mechanisms to Treatments: Insights into Peripheral and Central Sensitisation |
Stephanie Smith, United Kingdom Hans-Georg Schaible, Germany Serge Perrot, France Oral Abstract Presenter: Eoin Kelleher, United Kingdom |
|
| Passive Transfer of Fibromyalgia Syndrome and CRPS – Towards Effective Symptom Relief |
Andreas Goebel, United Kingdom Karla Sanchez, United States Amir Minerbi, Israel |
|
| From Bench To Clinic: Three Novel Therapeutic Targets for Chronic Pain on the Path to Clinical Use |
Cyril Rivat, France Niels Eijkelkamp, Netherlands Aziz Moqrich, France Cyril Rivat, France |
